MIRA Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing novel oral therapeutics for neurologic, neuropsychiatric, metabolic, and addiction-related disorders. The company holds exclusive U.S., Canada, and Mexico rights to three drug candidates: Ketamir-2 (oral NMDA receptor modulator, completed Phase 1 for neuropathic pain), MIRA-55 (cannabinoid analog in preclinical development for inflammatory pain and CNS conditions), and SKNY-1 (preclinical oral candidate for obesity and nicotine dependence). All three compounds have been reviewed by the DEA and are not classified as controlled substances.
expected 2026-12-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001493152-26-014001 | EDGAR | 68K words |
| 2025-03-28 | 2024-12-31 | 0001641172-25-001183 | EDGAR | 74K words |
| 2024-04-01 | 2023-12-31 | 0001493152-24-012141 | EDGAR | 78K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001493152-26-037366 | EDGAR | 18K words |
| 2025-11-13 | 2025-09-30 | 0001493152-25-022112 | EDGAR | 15K words |
| 2025-08-14 | 2025-06-30 | 0001641172-25-024077 | EDGAR | 13K words |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010301 | EDGAR | 12K words |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044747 | EDGAR | 10K words |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031612 | EDGAR | 11K words |
| 2024-05-13 | 2024-03-31 | 0001493152-24-018908 | EDGAR | 11K words |
| 2023-11-13 | 2023-09-30 | 0001493152-23-040517 | EDGAR | 15K words |
| 2023-09-15 | 2023-06-30 | 0001493152-23-032778 | EDGAR | 13K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-17 | 0001493152-26-043051 | EDGAR | 1K words |
| 2026-09-16 | 0001493152-26-042927 | EDGAR | 1K words |
| 2026-09-01 | 0001493152-26-040930 | EDGAR | 1K words |
| 2026-08-06 | 0001493152-26-036262 | EDGAR | 1K words |
| 2026-07-31 | 0001493152-26-035665 | EDGAR | 1K words |
| 2026-03-23 | 0001493152-26-012085 | EDGAR | 1K words |
| 2026-03-03 | 0001493152-26-008707 | EDGAR | 1K words |
| 2026-02-02 | 0001493152-26-004739 | EDGAR | 1K words |
| 2025-12-22 | 0001493152-25-028619 | EDGAR | 1K words |
| 2025-12-05 | 0001493152-25-026445 | EDGAR | 1K words |
91 total filings indexed. 69 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001904286 |
| Ticker | MIRA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | FL |
| Website | https://www.mirapharmaceuticals.com |
| Listed | 2023-08-03 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MIRA (~200 tokens, structured JSON with cryptographic provenance)